Show simple item record

A Multifaceted Evaluation of National Off-label Neurology Applications

dc.contributor.authorAlkan, Ali
dc.contributor.authorUZUN ADATEPE, Nurten
dc.contributor.authorRahmanlar, Hanife
dc.contributor.authorBayar, Banu
dc.contributor.authorGursoz, Hakki
dc.contributor.authorYurtogullari, Sukran
dc.date.accessioned2021-03-02T17:07:49Z
dc.date.available2021-03-02T17:07:49Z
dc.date.issued2020
dc.identifier.citationYurtogullari S., Rahmanlar H., Alkan A., Bayar B., Gursoz H., UZUN ADATEPE N., "A Multifaceted Evaluation of National Off-label Neurology Applications", TURKISH JOURNAL OF NEUROLOGY, cilt.26, sa.3, ss.235-241, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_2aa2d6df-4edc-42d0-b9d0-7be138800537
dc.identifier.urihttp://hdl.handle.net/20.500.12627/3613
dc.identifier.urihttps://doi.org/10.4274/tnd.2020.37791
dc.description.abstractObjective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate the most common neurologic drugs relevant to off-label prescribing and the most prescribed diagnosis, demographic and medical characteristics of patients with OLDU applications in Turkey.
dc.language.isoeng
dc.subjectTıp
dc.subjectNöroloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleA Multifaceted Evaluation of National Off-label Neurology Applications
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF NEUROLOGY
dc.contributor.departmentAnkara Ataturk Training & Research Hospital , ,
dc.identifier.volume26
dc.identifier.issue3
dc.identifier.startpage235
dc.identifier.endpage241
dc.contributor.firstauthorID2360832


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record